RBI
UTHR icon

Raiffeisen Bank International’s United Therapeutics UTHR Stock Holding History

Raiffeisen Bank International’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.1K Sell
35
-17
-33% -$9.57K ﹤0.01% 668
2026
Q1 		$30.6K Hold
52
– – ﹤0.01% 604
2025
Q4 		$25.8K Hold
52
– – ﹤0.01% 605
2025
Q3 		$22.1K Sell
52
-1,660
-97% -$558K ﹤0.01% 607
2025
Q2 		$490K Hold
1,712
– – 0.01% 377
2025
Q1 		$526K Hold
1,712
– – 0.01% 362
2024
Q4 		$612K Buy
+1,712
New +$629K 0.01% 325

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Raiffeisen Bank International's UTHR Position: Q2 2026 in Review

Raiffeisen Bank International reduced its United Therapeutics (UTHR) stake by 33% in Q2 2026, selling an estimated $9.57K and leaving 35 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #668.

Raiffeisen Bank International first reported a position in UTHR in Q4 2024 and has held it in 7 quarters since. The position peaked at $612K in Q4 2024. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Raiffeisen Bank International held 35 shares of United Therapeutics worth $19.1K as of Q2 2026.
  • Raiffeisen Bank International sold 17 United Therapeutics shares in Q2 2026, an estimated $9.57K.
  • United Therapeutics made up ﹤0.01% of Raiffeisen Bank International's portfolio in Q2 2026, its #668 holding.
  • Raiffeisen Bank International first reported a position in United Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Raiffeisen Bank International's United Therapeutics position peaked at $612K in Q4 2024.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.